Document is current
Any future updates will be listed below
-
Authors
Hennion, Nathan
Bedart, Corentin https://orcid.org/0000-0003-2430-3703
Vandomber, Léonie
Gottrand, Frédéric https://orcid.org/0000-0002-5290-0436
Humez, Sarah
Chenivesse, Cécile
Desseyn, Jean-Luc https://orcid.org/0000-0001-6876-8049
Gouyer, Valérie https://orcid.org/0000-0002-4223-7060
-
Funding
Funding for this research was provided by:
Région Hauts-de-France (Région Hauts-de-France)
CHU of Lille (CHU of Lille)
- License Information
-
More Information
Article History
Received: 19 September 2024
Revised: 5 February 2025
Accepted: 10 February 2025
First Online: 13 March 2025
Declarations
:
: The animal protocols were in accordance with the French Guide for the Care and Use of Laboratory Animals and with the guidelines of the European Union. Animal housing and all experimental procedures were approved by and performed according to the National Institutional Animal Ethics Committees and institutional guidelines (APAFIS#25481-2020050415255797 v4).
: Author SH and CC declare they have no financial interests. SH declares personal fees from Boehringer-Ingelheim, Merck & Co, Bristol Myers Squibb. CC declares grants from AstraZeneca, GSK, Novartis, Santelys, personal fees from ALK-Abello, AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK, Sanofi and congress support from AstraZeneca, Boehringer-Ingelheim, Chiesi, Novartis, Sanofi. Other authors have no relevant financial or non-financial interests to disclose.
